Ceribell (CBLL) Notes Payables (2023)
Ceribell (CBLL) reported Notes Payables of $11.8 million for Q4 2023.
Ceribell (CBLL) Notes Payables (2023) Analysis & Trends
Ceribell has reported Notes Payables for 1 years, with the latest figure at $11.8 million in Q4 2023.
- For the quarter ending Q4 2023, Notes Payables changed N/A year-over-year to $11.8 million; the trailing twelve-month figure through Dec 2023 stood at $11.8 million (changed N/A YoY), and the FY2023 full-year result was $11.8 million, changed N/A from the prior year.
- Notes Payables for Q4 2023 stood at $11.8 million.
- The five-year high for Notes Payables was $11.8 million in Q4 2023, with the low at $11.8 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Ceribell | 679.82 Mn | 538.64 Mn | 23.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 11.83 Mn |